Gan Partners, together with its funds ( is pleased to announce its investment in Adenocyte™ ( a medical technology company ...

Faced with a future of evaporating Xtandi sales, Astellas has set out ambitions to license fresh assets while also continuing ...

MarketBeat Week in Review – 7/15 - 7/19 IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress ...

Novartis has a more mature AI narrative than many industrial or healthcare peers. The company says it has already developed more than 100 AI use cases across R&D, operations, and commercial activity, ...

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

Immunotherapy has transformed the management of many malignancies, yet a substantial proportion of patients either fail to respond or eventually develop ...